Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset

Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?

(2021) Elvira Favoino et al.   AUTOIMMUNITY REVIEWS

Mechanism of miR-218-5p in autophagy, apoptosis and oxidative stress in rheumatoid arthritis synovial fibroblasts is mediated by KLF9 and JAK/STAT3 pathways

(2021) Ming Chen et al.   JOURNAL OF INVESTIGATIVE MEDICINE

POS0198 EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

(2021) P. J. Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Large-scale integration of the plasma proteome with genetics and disease

(2021) Egil Ferkingstad et al.   NATURE GENETICS

FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease

(2020) Saedis Saevarsdottir et al.   NATURE

Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci

(2020) Eunji Ha et al.   ANNALS OF THE RHEUMATIC DISEASES

Targeting FLT3 mutations in AML: review of current knowledge and evidence

(2019) Naval Daver et al.   LEUKEMIA

FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications

(2019) Julhash U. Kazi et al.   PHYSIOLOGICAL REVIEWS

DBDS Genomic Cohort, a prospective and comprehensive resource for integrative and temporal analysis of genetic, environmental and lifestyle factors affecting health of blood donors

(2019) Thomas Folkmann Hansen et al.   BMJ Open

What Makes a pDC: Recent Advances in Understanding Plasmacytoid DC Development and Heterogeneity

(2019) Andrea Musumeci et al.   Frontiers in Immunology

The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors

(2019) Katie Bechman et al.   PHARMACOLOGICAL RESEARCH

Association between rs7574865 polymorphism in STAT4 gene and rheumatoid arthritis: An updated meta-analysis

(2019) Wenyan Gao et al.   European Journal of Internal Medicine

Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder

(2019) Olafur O. Gudmundsson et al.   Translational Psychiatry

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

(2019) Eric F. Morand et al.   NEW ENGLAND JOURNAL OF MEDICINE

TheSTAT4SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE

(2018) Niklas Hagberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study

(2018) Tina Marie Kringelbach et al.   BMJ Open

Rheumatoid arthritis

(2018) Josef S. Smolen et al.   Nature Reviews Disease Primers

Genomic atlas of the human plasma proteome

(2018) Benjamin B. Sun et al.   NATURE

Genetics of rheumatoid arthritis: 2018 status

(2018) Yukinori Okada et al.   ANNALS OF THE RHEUMATIC DISEASES

The UK Biobank resource with deep phenotyping and genomic data

(2018) Clare Bycroft et al.   NATURE

Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators

(2017) Hung N. Nguyen et al.   IMMUNITY

Pathogenetic insights from the treatment of rheumatoid arthritis

(2017) Iain B McInnes et al.   LANCET

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

(2017) Daniella M. Schwartz et al.   NATURE REVIEWS DRUG DISCOVERY

Connecting genetic risk to disease end points through the human blood plasma proteome

(2017) Karsten Suhre et al.   Nature Communications

Cohort Profile Update: The Norwegian Mother and Child Cohort Study (MoBa)

(2016) Per Magnus et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Weighting sequence variants based on their annotation increases power of whole-genome association studies

(2016) Gardar Sveinbjornsson et al.   NATURE GENETICS

Family history of rheumatoid arthritis: an old concept with new developments

(2016) Thomas Frisell et al.   Nature Reviews Rheumatology

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity

(2016) C. A. Dendrou et al.   Science Translational Medicine

The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO

(2016) Else Helene Ibfelt et al.   Clinical Epidemiology

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis

(2015) S Hong Lee et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Large-scale whole-genome sequencing of the Icelandic population

(2015) Daniel F Gudbjartsson et al.   NATURE GENETICS

A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides

(2014) L Bossini-Castillo et al.   ANNALS OF THE RHEUMATIC DISEASES

Role of Synovial Fibroblasts in Rheumatoid Arthritis

(2014) S. Lefevre et al.   CURRENT PHARMACEUTICAL DESIGN

Genetics of rheumatoid arthritis contributes to biology and drug discovery

(2013) Yukinori Okada et al.   NATURE

Association of the IRF5 rs2004640 polymorphism with rheumatoid arthritis: a meta-analysis

(2013) Xiuzhi Jia et al.   RHEUMATOLOGY INTERNATIONAL

FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis

(2013) Maria I Ramos et al.   ARTHRITIS RESEARCH & THERAPY

SB1578, a Novel Inhibitor of JAK2, FLT3, and c-Fms for the Treatment of Rheumatoid Arthritis

(2012) B. Madan et al.   JOURNAL OF IMMUNOLOGY

A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis

(2010) L. Padyukov et al.   ANNALS OF THE RHEUMATIC DISEASES

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) Daniel Aletaha et al.   ARTHRITIS AND RHEUMATISM

Intra-Articular Fms-Like Tyrosine Kinase 3 Ligand Expression Is a Driving Force in Induction and Progression of Arthritis

(2008) Mats Dehlin et al.   PLoS One